Although all of the 5 signature genes were not included in the previous signature panels for CRC [6–9, 24], some of them were found to be associated with the progression and prognosis of CRC (including ASB2, GPR15, TCL1A, and PRPH) [28–31]. This evidence concerns the gene PRPH and colorectal carcinoma.